BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15902300)

  • 41. Adult aggressive natural killer cell leukemia.
    Zhang H; Meng Q; Yin W; Xu L; Lie L
    Am J Med Sci; 2013 Jul; 346(1):56-63. PubMed ID: 23241562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms.
    Sekiguchi N; Asano N; Ito T; Momose K; Momose M; Ishida F
    Int J Hematol; 2012 Oct; 96(4):461-8. PubMed ID: 22890551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis.
    Morice WG; Leibson PJ; Tefferi A
    Leuk Lymphoma; 2001 Apr; 41(3-4):277-84. PubMed ID: 11378540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge.
    You E; Park CJ; Lee MY; Cho YU; Jang S; Lee JH; Lee JH; Lee KH
    Int J Med Sci; 2023; 20(2):206-210. PubMed ID: 36794163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early viral replication in lymph nodes provides HIV with a means by which to escape NK-cell-mediated control.
    Luteijn R; Sciaranghella G; van Lunzen J; Nolting A; Dugast AS; Ghebremichael MS; Altfeld M; Alter G
    Eur J Immunol; 2011 Sep; 41(9):2729-40. PubMed ID: 21630248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variable manifestation in natural killer cell leukaemia.
    Kuroda J; Kimura S; Kobayashi Y; Jyoko N; Kamitsuji Y; Murotani Y; Fukuda W; Akaogi T; Hayashi H; Yoshikawa T; Maekawa T
    Clin Lab Haematol; 2003 Aug; 25(4):239-45. PubMed ID: 12890163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic natural killer cell lymphocytosis.
    Tefferi A
    Leuk Lymphoma; 1996 Jan; 20(3-4):245-8. PubMed ID: 8624463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 18F-FDG PET for diagnosis and response assessment for aggressive NK cell leukemia.
    Park JA
    Clin Nucl Med; 2014 Apr; 39(4):e281-2. PubMed ID: 23751830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Aggressive NK-cell leukemia: report of nine cases and review of literature].
    Sino-US Shanghai Leukemia Cooperative Group
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):116-9. PubMed ID: 16732967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retroviral expression screening of oncogenes in natural killer cell leukemia.
    Choi YL; Moriuchi R; Osawa M; Iwama A; Makishima H; Wada T; Kisanuki H; Kaneda R; Ota J; Koinuma K; Ishikawa M; Takada S; Yamashita Y; Oshimi K; Mano H
    Leuk Res; 2005 Aug; 29(8):943-9. PubMed ID: 15978945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NK cell surveillance of hematological malignancies. Therapeutic implications and regulation by chemokine receptors.
    Tomaipitinca L; Russo E; Bernardini G
    Mol Aspects Med; 2021 Aug; 80():100968. PubMed ID: 34045078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemokine networks modulating natural killer cell trafficking to solid tumors.
    Yao X; Matosevic S
    Cytokine Growth Factor Rev; 2021 Jun; 59():36-45. PubMed ID: 33495094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Three cases of aggressive natural killer cell leukemia with a lethal hemorrhagic complication.
    Okuno Y; Tatetsu H; Nosaka K; Mitsuya H
    J Clin Exp Hematop; 2012; 52(2):101-6. PubMed ID: 23037625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue Sites.
    Gao LM; Zhao S; Liu WP; Zhang WY; Li GD; Küçük C; Hu XZ; Chan WC; Tang Y; Ding WS; Yan JQ; Yao WQ; Wang JC
    Am J Surg Pathol; 2016 Jun; 40(6):836-46. PubMed ID: 26975038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cutaneous findings associated with chronic natural killer cell lymphocytosis.
    Vanness ER; Davis MD; Tefferi A
    Int J Dermatol; 2002 Dec; 41(12):852-7. PubMed ID: 12492968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation.
    Lachota M; Zielniok K; Palacios D; Kanaya M; Penna L; Hoel HJ; Wiiger MT; Kveberg L; Hautz W; Zagożdżon R; Malmberg KJ
    EBioMedicine; 2023 Oct; 96():104811. PubMed ID: 37741009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chronic natural killer cell lymphocytosis: eight cases report and literature review].
    Peng G; Zhao X; Xiong Y; Li Y; Li Y; Li J; Ye L; Fan H; Song L; Yang W; Wu Z; Jing L; Shang L; Wang H; Zhang L; Zhou K; Zhang F
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):609-13. PubMed ID: 25052603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Six cases of aggressive natural killer-cell leukemia in a Chinese population.
    Zhang Q; Jing W; Ouyang J; Zeng H; George SK; Liu Z
    Int J Clin Exp Pathol; 2014; 7(6):3423-31. PubMed ID: 25031771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aggressive natural killer cell leukemia: report of a case in a Caucasian boy.
    Mateu R; Badell I; Alcala A; Estivill C; Rubiol E; Nomdedéu J; Soler J
    Haematologica; 1998 Feb; 83(2):190-2. PubMed ID: 9549932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
    Kameda K; Yanagiya R; Miyatake Y; Carreras J; Higuchi H; Murayama H; Ishida T; Ito A; Iida S; Fukuhara N; Harigae H; Fujioka Y; Takahashi N; Wada H; Ishida F; Nakazawa H; Ishihara R; Murakami Y; Tagawa H; Matsuura T; Nakagawa S; Iwabuchi S; Hashimoto S; Imadome KI; Nakamura N; Ishizawa K; Kanda Y; Ando K; Kotani A
    Blood; 2023 Jul; 142(4):352-364. PubMed ID: 37146246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.